Colostrinin vs Leucine Enkephalin (Leu-Enkephalin)
A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Colostrinin
Proline-rich polypeptide complex isolated from ovine (sheep) colostrum. Originally researched as an Alzheimer's disease modulator, colostrinin has shown ability to stabilize cognitive function and reduce progression in mild-to-moderate Alzheimer's patients in double-blind trials. Also studied for immune modulation and anti-aging properties via cytokine balance normalization.
Full profileLeucine Enkephalin (Leu-Enkephalin)
One of the two primary endogenous enkephalins, alongside met-enkephalin. This pentapeptide (Tyr-Gly-Gly-Phe-Leu) acts primarily on δ-opioid receptors and secondarily on μ-opioid receptors. Research interests span pain modulation, neuroprotection, mood regulation, and immune system modulation. Extremely short half-life in vivo due to rapid enkephalinase degradation.
Full profile| Colostrinin | Leucine Enkephalin (Leu-Enkephalin) | |
|---|---|---|
| Category | Nootropic & Cognitive | Nootropic & Cognitive |
| Also known as | PRP (proline-rich polypeptide), ND, colostrum neuropeptide, CLN, ovine proline-rich polypeptide | Leu5-enkephalin, YGGFL, L-enkephalin, endogenous opioid pentapeptide |
| Evidence | Research-stage | Research-stage |
| Dosing range | 100mcg–400mcg mcg, sublingual, on a 3 days on / 3 days off cycle | 0.1mg–1mg mg, Intranasal or SC; extremely short half-life requires frequent dosing or continuous delivery |
| Administration | Sublingual tablet/drop | Intranasal, Subcutaneous injection, Intraventricular (research only) |
| Key side effects | Generally well-tolerated, Mild GI discomfort, Rare hypersensitivity (relevant for dairy protein sensitivity), Mild fatigue (initial days) | Tolerance development with repeated use (opioid receptor class effect), Mild euphoria (δ-opioid mediated), Nausea (at high doses), Constipation (opioid class effect at high doses) |
| Cited sources | 2 references | 2 references |
Key differences
- Administration: Colostrinin — Sublingual tablet/drop; Leucine Enkephalin (Leu-Enkephalin) — Intranasal, Subcutaneous injection, Intraventricular (research only).
- Dosing units differ: Colostrinin is dosed in mcg, Leucine Enkephalin (Leu-Enkephalin) in mg — they operate at different scales.
- Frequency: Colostrinin is typically sublingual, on a 3 days on / 3 days off cycle; Leucine Enkephalin (Leu-Enkephalin) is Intranasal or SC; extremely short half-life requires frequent dosing or continuous delivery.
How each works
Colostrinin
Colostrinin modulates dendritic cell maturation and shifts cytokine balance toward anti-inflammatory patterns (reduced IL-6, TNF-α; increased IL-10). In neurological models, it reduces amyloid-β aggregation, decreases oxidative stress, and upregulates NGF while modulating the HPA axis stress response. A Polish double-blind trial showed statistically significant cognitive stabilization in mild-to-moderate AD patients over 15 weeks.
Leucine Enkephalin (Leu-Enkephalin)
Leu-enkephalin was one of the first endogenous opioid peptides characterized, following the discovery of opioid receptors in 1973. It preferentially activates δ-opioid receptors (DOR) over μ-opioid receptors (MOR), producing analgesia, modulation of GABA release, and reward pathway activation. Enkephalinase (neprilysin/NEP, CD10) cleaves the Gly-Phe bond within ~2 minutes IV, necessitating stable analogues or NEP inhibitors for research applications.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.